Bunkerhill MAC vs Study Watch

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Bunkerhill Health
VS
by Verily

AI Verdict

Bunkerhill MAC offers AI-powered detection and quantification of mitral annular calcification from CT scans, serving as a clinical decision support tool for cardiovascular risk. Conversely, Verily Study Watch is a wearable device for continuous physiological monitoring in clinical research, collecting real-time data such as ECG and heart rate. While both contribute to cardiology insights with AI, Bunkerhill MAC focuses on image analysis for diagnosis, whereas Study Watch emphasizes real-time data acquisition from individuals.

Choose Bunkerhill MAC if…

Choose Bunkerhill MAC if your organization aims to proactively identify cardiovascular risk in a broad patient population by analyzing routine, non-gated chest CT scans already performed. This AI algorithm is ideal for automating the detection and quantification of mitral annular calcification (MAC) and integrating these insights into existing EHRs for streamlined care coordination and follow-up.

View Bunkerhill MAC →

Choose Study Watch if…

Choose Verily Study Watch if your clinical research requires continuous, high-fidelity physiological monitoring of participants over extended periods. This prescription-only wearable is best suited for studies needing precise, long-term data collection on parameters like ECG, heart rate, and movement to analyze disease progression or treatment efficacy within a dedicated research platform.

View Study Watch →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Bunkerhill MAC Study Watch
Deployment Cloud-based, integrates with EHRs. The Study Watch is a wrist-worn, multi-sensor wearable device used for data collection in clinical trials. Data from the watch is encrypted and sent securely to the Verily Cloud using a USB syncing and charging cradle and a wireless connectivity bridge (Verily Study Hub).
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Bunkerhill MAC

Tool A integrates seamlessly into existing radiology workflows, analyzing routine CT scans and requiring minimal new user interaction for clinicians. Tool B, as a patient-facing wearable, introduces the complexities of patient adherence and device management, which can be more involved for healthcare providers.

Clinical Value

Bunkerhill MAC

Tool A offers direct, actionable clinical value by identifying and quantifying Mitral Annular Calcification (MAC) on existing CT scans, enabling early cardiovascular risk stratification and care coordination. While Tool B provides valuable continuous physiological monitoring for research and general health tracking, Tool A's specific diagnostic aid for a critical cardiovascular condition offers a more immediate and targeted clinical impact.

Pricing & Value

Tie

Both tools lack publicly available pricing information, making a direct comparison of their value propositions impossible. As both are enterprise-level solutions likely requiring custom contracts, neither can be declared a winner in this dimension without further data.

Enterprise Readiness

Bunkerhill MAC

Tool A explicitly highlights seamless integration with existing EHRs and clinical systems, which is crucial for enterprise adoption and workflow efficiency. While Tool B is FDA-cleared and cloud-based, Tool A's stated focus on integrating into established clinical IT infrastructure gives it a slight edge in readiness for large-scale deployment.

Innovation

Bunkerhill MAC

Tool A leverages 'Generative AI for clinical reasoning and action' and integrates with the Carebricks platform for advanced AI capabilities, suggesting a more sophisticated application of AI beyond mere data analysis. While Tool B's multi-sensor continuous monitoring and machine learning are innovative, Tool A's generative AI component appears to represent a more cutting-edge approach in the AI healthcare space.

Support & Docs

Tie

Neither the provided structured facts nor general web searches offer sufficient specific details regarding public support channels, documentation, or service level agreements for either tool. Due to this lack of comparative information, it is not possible to definitively pick a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Bunkerhill MAC Study Watch
Name Bunkerhill MAC Study Watch
Description FDA-cleared AI algorithm that detects and quantifies mitral annular calcification (MAC) on routine CT scans, aiding early cardiovascular risk identification and care coordination within the Carebricks platform. Prescription-only, sensor-based wearable device for non-invasive, continuous physiological monitoring in clinical research, collecting data like ECG, heart rate, and movement for analysis in Verily's cloud platform.
Company Bunkerhill Health Verily Life Sciences
Primary Function AI-powered detection and quantification of Mitral Annular Calcification (MAC) on routine, non-gated chest CT scans. Continuous physiological monitoring with multiple sensors (ECG, heart rate, electrodermal activity, inertial movements) for clinical research.
Categories Cardiology AI, Clinical Decision Support & Reference Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties Cardiology, Radiology Cardiology, Neurology, Sleep Medicine

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill MAC and Study Watch.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Bunkerhill MAC is an FDA-cleared AI algorithm designed to detect and quantify mitral annular calcification (MAC) on routine CT scans, aiding in early cardiovascular risk identification and care coordination. Verily Study Watch is a prescription-only, FDA-cleared wearable device for non-invasive, continuous physiological monitoring, collecting data like ECG, heart rate, and movement primarily for clinical research.
Bunkerhill MAC is cloud-based and integrates with existing EHRs and clinical systems via the Carebricks platform, supporting automated workflows for follow-up and care coordination. Verily Study Watch uploads data from the device to Verily's cloud platform for processing with algorithms and machine learning.
Bunkerhill MAC analyzes routine, non-gated chest CT scans to detect and quantify Mitral Annular Calcification. Verily Study Watch collects continuous physiological data through multiple sensors, including ECG, heart rate, electrodermal activity, and inertial movements.
Bunkerhill MAC is primarily relevant for Cardiology and Radiology due to its focus on CT scan analysis for cardiovascular risk. Verily Study Watch is relevant for Cardiology, Neurology, and Sleep Medicine, given its broad physiological monitoring capabilities.
Bunkerhill MAC supports clinical decision-making by providing AI-powered detection and quantification of MAC, aiding in early cardiovascular risk identification and enabling automated workflows for follow-up. Verily Study Watch offers continuous physiological monitoring, including on-demand single-channel ECG and irregular pulse monitoring, which can inform clinical research and potentially personalized care decisions.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.